Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Loading...
Thumbnail Image

Embargo End Date

Authors

Went, M
Sud, A
Försti, A
Halvarsson, B-M
Weinhold, N
Kimber, S
van Duin, M
Thorleifsson, G
Holroyd, A
Johnson, DC
Li, N
Orlando, G
Law, PJ
Ali, M
Chen, B
Mitchell, JS
Gudbjartsson, DF
Kuiper, R
Stephens, OW
Bertsch, U
Broderick, P
Campo, C
Bandapalli, OR
Einsele, H
Gregory, WA
Gullberg, U
Hillengass, J
Hoffmann, P
Jackson, GH
Jöckel, K-H
Johnsson, E
Kristinsson, SY
Mellqvist, U-H
Nahi, H
Easton, D
Pharoah, P
Dunning, A
Peto, J
Canzian, F
Swerdlow, A
Eeles, RA
Kote-Jarai, Z
Muir, K
Pashayan, N
Nickel, J
Nöthen, MM
Rafnar, T
Ross, FM
da Silva Filho, MI
Thomsen, H
Turesson, I
Vangsted, A
Andersen, NF
Waage, A
Walker, BA
Wihlborg, A-K
Broyl, A
Davies, FE
Thorsteinsdottir, U
Langer, C
Hansson, M
Goldschmidt, H
Kaiser, M
Sonneveld, P
Stefansson, K
Morgan, GJ
Hemminki, K
Nilsson, B
Houlston, RS
PRACTICAL consortium

Document Type

Journal Article

Date

2018-09-13

Date Accepted

2018-06-06

Abstract

Genome-wide association studies (GWAS) have transformed our understanding of susceptibility to multiple myeloma (MM), but much of the heritability remains unexplained. We report a new GWAS, a meta-analysis with previous GWAS and a replication series, totalling 9974 MM cases and 247,556 controls of European ancestry. Collectively, these data provide evidence for six new MM risk loci, bringing the total number to 23. Integration of information from gene expression, epigenetic profiling and in situ Hi-C data for the 23 risk loci implicate disruption of developmental transcriptional regulators as a basis of MM susceptibility, compatible with altered B-cell differentiation as a key mechanism. Dysregulation of autophagy/apoptosis and cell cycle signalling feature as recurrently perturbed pathways. Our findings provide further insight into the biological basis of MM.

Citation

Nature communications, 2018, 9 (1), pp. 3707 - ?

Source Title

Publisher

ISSN

2041-1723

eISSN

2041-1723

Research Team

Aetiological Epidemiology
Cancer Genomics
Myeloma Group
Oncogenetics

Notes